Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Rapidly administered sequential high dose(HD) cyclophosphamide(CPA), melphalan(M), thiotepa(TT) supported by filgrastim(G) + peripheral blood progenitors(PBP) in metastatic breast cancer(MBC) patients(PTS)
    Meeting Abstract

    Raptis, G.; Crown, J.; Vahdat, L.; Fennelly, D.; Hamilton, N.; Hudis, C.; Gilewski, T.; Seidman, A.; Currie, V.; Reich, L.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • AML1B is but not the AML 1/ETO fusion protection can transactivate the GM-CSF promoter
    Meeting Abstract

    Frank, R.; Zhang, J.; Hiebert, S.; Meyers, S.; Nimer, S.
    Blood (1994)

    Fulltext@MSK | Save
  • Treatment of HLA-mismatched, related allogeneic bone marrow graft failure with granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells
    Meeting Abstract

    Wuest, D.; Reich, L.; Collins, N.; Small, T.; Gillio, A.
    Artificial Organs (1994)

    Fulltext@MSK | Save
  • Modulating multidrug resistance with tamoxifen in patients with advanced leukemia
    Meeting Abstract

    Berman, E.; McBride, M.; Tong, W.
    Annals of Hematology (1994)

    Fulltext@MSK | Save
  • Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant M-VAC
    Meeting Abstract

    Sarkis, A.; Bajorin, D.; Netto, G.; Schultz, P.; Zhang, Z. F.; Cordon-Cardo, C.; Scher, H.; Reuter, V. E.
    Laboratory Investigation (1994)

    Fulltext@MSK | Save
  • Overexpression of p53 in the transformation of follicular lymphoma
    Meeting Abstract

    Jaslow, R.; Offit, K.; Lo Coco, F.; Louie, D. C.
    Laboratory Investigation (1994)

    Fulltext@MSK | Save
  • Radioimmunotherapy (RIT) with I-131 monoclonal antibody (MAB) CC49 and deoxyspergualine (DSG) in metastatic colon cancer
    Meeting Abstract

    Divgi, C. R.; Scott, A. M.; Young, C.; Kemeny, N.; Conti, J.; Daghighian, F.; Broussard, E.; Schlom, J.; Larson, S. M.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save
  • Clinical implementation of new region-specific S-values for marrow dosimetry: Dose distribution vs mean marrow dose in radioimmunotherapy of leukemia
    Meeting Abstract

    Sgouros, G.; Stabin, M. G.; Jureidini, I. M.; Scott, A. S.; Graham, M. C.; Larson, S. M.; Scheinberg, D. A.; Eckerman, K. F.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save
  • Phase II radioimmunotherapy (RIT) trial with I-131 labeled monoclonal antibody CC49 in TAG-72 expressing breast cancer
    Meeting Abstract

    Kostakoglu, L.; Divgi, C. R.; Gilewski, T.; Theodoulou, M.; Schlom, J.; Larson, S. M.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save